JPRN-UMIN000009495
Completed
未知
Clinical study to evaluate the efficacy of a new vitamin D derivative to the patients with a long history of bisphosphonate treatment - Clinical study to evaluate the efficacy of a new vitamin D derivative to the patients with a long history of bisphosphonate treatment
Dept. of Orthopedic Surgery, Keio Univesity, School of Medicine0 sites120 target enrollmentDecember 6, 2012
ConditionsOsteoporosis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Osteoporosis
- Sponsor
- Dept. of Orthopedic Surgery, Keio Univesity, School of Medicine
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Those who are not physically and mentally sound.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
The effect of vitamin C on type 2 diabetes patient.IRCT20180627040253N1Mashhad University of Medical Sciences54
Not yet recruiting
Phase 3
Shirishadi Malhar & Parushakadi Yog in the Management of KIKKISA w.s.r. to STRIAE GRAVIDARUMHealth Condition 1: L929- Granulomatous disorder of the skinand subcutaneous tissue, unspecifiedHealth Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereCTRI/2023/07/055029Government of Himachal Pradesh
Active, not recruiting
Not Applicable
Testing a food supplement for reducing stress on studentsStressMental and Behavioural DisordersISRCTN14084189ROELMI HPC Srl42
Recruiting
Phase 3
Assessing the effectiveness of topical peppermint cream and orally ingestible peppermint oxymel mouthwash on halitosis and vomiting of breast cancer patients during chemotherapyBreast cancer patients treated with chemotherapy drugs.Malignant neoplasm of breastIRCT20201219049763N1Iranian academic center for education culture and research225
Recruiting
Not Applicable
The clinical trial to examine the efficacy of the intravitreal injection of anti-VEGF antibody Bevacizumab(Avastin) for severe retinopathy of prematurity.Retinopathy of prematurityJPRN-UMIN000018069Gunma University Hospital Department of Ophthalmology4